Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unresectable Pancreatic Cancer 1Small Cell Lung Carcinoma 1Liver, Cancer of, Non-Resectable 1Colorectal Neoplasms 1Advanced Intestinal Cancer 1Advanced Breast Cancer 1

Interventions

Oxaliplatin 15Fluorouracil 13Bevacizumab 13Leucovorin 10Capecitabine 8Folfox protocol 7Irinotecan 6IFL protocol 4Cetuximab 4Folic Acid 3Aspirin 3atezolizumab 2XELOX 2Surgical Procedures, Operative 2Magnetic Resonance Spectroscopy 2Drug Therapy 2Chemotherapy, Adjuvant 2trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1sulindac sulfone 1spartalizumab 1sacituzumab govitecan 1regorafenib 1raltitrexed 1pertuzumab 1irinotecan sucrosofate 1folfirinox 1envafolimab 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Colorectal Neoplasms × Cryosurgery × Clear all
NCT01741038 2020-01-22

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Mirror Biologics, Inc.

Phase 2/3 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡